← Back
$AKTS All transactions

Aktis Oncology, Inc.

C

$ Value

Shares

19,631

Price

Filed

Jan 12

Insider

Name

Segal Lloyd Mitchell

Title

CIK

0001477123

Roles

Director

Transaction Details

Transaction Date

2026-01-12

Code

C

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

19,631

Footnotes

Represents shares of the Issuer's Common Stock received upon conversion of shares of the reported series of preferred stock on a 3.8044-for-1 basis without payment of further consideration. | Consists of shares held by Arvala, Inc.(f/k/a 3996953 Canada Inc.). The Reporting Person is the president and sole stockholder of Arvala, Inc. and may be deemed to share the voting and dispositive power over the shares held by Arvala, Inc. | The Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock had no expiration date and automatically converted into the Issuer's Common Stock on a 3.8044-for-1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock.

Filing Info

Accession No.

0001193125-26-010575

Form Type

4

Issuer CIK

0002035832

Segal Lloyd Mitchell's History

Date Ticker Type Value
2026-01-12 AKTS C
2026-01-12 AKTS C $0
2026-01-12 AKTS C $0

Other Insiders at AKTS (90d)

Insider Bought Sold Last
Gormley Glenn 2026-04-15